How many people on Medicare need insulin?

Editorial team Published on

Over 3.3 million Medicare beneficiaries use insulin.

Key Details

  • Diabetes prevalence: About 1 in 3 people on Medicare have diabetes.
  • Cost protection: Under the Inflation Reduction Act, out-of-pocket costs for a 30-day supply of any Medicare-covered insulin are capped at $35.
  • Coverage types:
    • Part D covers most injected or inhaled insulin and disposable patch pumps.
    • Part B covers insulin delivered through a traditional, non-disposable durable medical equipment pump.

Is insulin still $35 for Medicare patients?

Yes, insulin is still capped at no more than $35 per month for a one-month supply of each covered insulin product for Medicare patients.

Key Details on the $35 Insulin Cap

  • Medicare Part D: Covers retail injectable and inhaled insulin, capping costs at $35 per month per product with no deductible.
  • Medicare Part B: Covers insulin used through a traditional traditional durable medical equipment (DME) infusion pump, also capped at $35 per month with no deductible.
  • No Deductibles: You do not have to pay a yearly deductible before the $35 cap kicks in for covered insulin.
  • Multiple Months: If you order a three-month supply, you will pay no more than $105 total per covered product ($35 per month).
  • Official Information: You can review official updates and covered products directly on the Medicare Insulin Coverage Page.

How much does a 30-day supply of insulin cost?

A 30-day supply of insulin typically costs $35 or less out-of-pocket for many patients due to recent federal caps, manufacturer savings programs, and generic alternatives, though list prices without discounts can range from $100 to over $1,000.

Costs by Coverage Type

  • Medicare: Capped at $35 per month for a 30-day supply of covered insulin under Medicare Part D and Part B, with no deductible.
  • Commercial / Private Insurance: Many major manufacturers and commercial plans cap out-of-pocket costs at $35 per month, and over half of U.S. states have enacted laws capping copays between $0 and $100 for state-regulated plans.
  • Without Insurance (Cash Price): Major manufacturers like Eli Lilly and Sanofi offer value savings programs limiting out-of-pocket costs to $35 per month, while retail cash prices or discount platforms like GoodRx vary widely depending on whether you choose brand-name vials, pre-filled pens, or authorized biosimilars.

Do all type 2 diabetics eventually need insulin?

No, not all people with type 2 diabetes eventually need insulin.

While type 2 diabetes is a progressive condition where the pancreas may produce less insulin over time, many individuals successfully manage their blood sugar for decades using only lifestyle modifications (like diet and exercise) and non-insulin medications (such as metformin or GLP-1 receptor agonists). Whether you will eventually need insulin depends on factors like genetics, how well your beta cells maintain function, and how effectively your overall treatment plan controls your blood sugar.

How much is insulin if you are on Medicare?

Under Medicare, you will pay no more than $35 for a one-month supply of each covered insulin product. Under rules established by the Inflation Reduction Act, you also do not have to pay a deductible for your covered insulin.

If you receive a three-month supply, your out-of-pocket cost is capped at $105 ($35 per month).

Key Details About Medicare Insulin Coverage

  • The Per-Product Rule: The $35 cap applies to each covered insulin product individually. If you use two different types of covered insulin (such as a fast-acting and a long-acting insulin), you will pay up to $35 for each, making it up to $70 total per month.
  • No Deductibles: The $35 maximum copay applies even if you haven't met your annual plan deductible yet.
  • Coverage Across Plans: This protection applies whether you get your prescription coverage through a standalone Medicare Part D plan or a Medicare Advantage (Part C) plan. It also applies to everyone who takes covered insulin, even if you qualify for the Extra Help program.
  • Potential for Lower Costs: Your actual cost could be lower than $35 if your specific plan has negotiated a lower rate or if a 25% cost-sharing rule works out in your favor.

How Medicare Covers Different Types of Insulin

How you take your insulin determines which part of Medicare covers it:

Delivery MethodMedicare Coverage TypeOut-of-Pocket Cost
Injections or Inhalation (pens, syringes, or inhaled insulin)Covered under Part D (or Medicare Advantage)Max $35 per month per covered insulin
Traditional Insulin Pump (considered Durable Medical Equipment)Covered under Part BMax $35 per month (Part B deductible does not apply)
Disposable Patch PumpsCovered under Part DThe insulin is capped at $35, but the disposable device itself may cost more.

A Note on Diabetes Supplies

While the insulin medication itself is capped, associated supplies follow separate rules:

  • Under Part D, necessary supplies to administer injections (like syringes, needles, gauze, and alcohol swabs) are covered, but they may be subject to normal plan deductibles and standard copays.
  • Blood sugar testing supplies (like glucose monitors, lancets, and test strips) are generally covered under Part B, where you typically pay 20% of the Medicare-approved amount after meeting your annual Part B deductible.

To ensure you pay the capped amount, double-check your plan’s formulary (drug list) using the Medicare Plan Finder tool to confirm that your specific brand of insulin is fully covered.

Medicare Insulin Savings

9 related questions found

Is insulin going to be cheaper in 2026?

Yes, insulin is becoming cheaper in 2026 due to expanded federal caps, new nonprofit manufacturing options, and lower list prices from major drug companies.

Key Affordability Changes in 2026

  • Medicare Caps and Reductions: The $35 monthly out-of-pocket cap for Medicare beneficiaries remains fully in place with no deductible required. Additionally, Medicare Part D out-of-pocket drug spending is capped at $2,100 total for the year, helping patients with complex diabetes needs.
  • New Low-Cost Options: Nonprofit manufacturer Civica Rx launched an affordable generic long-acting insulin (insulin glargine-yfgn) priced at a wholesale cost of $45 for five pens and a maximum retail price of $55 per box.
  • Manufacturer Programs and Biosimilars: Major insulin makers (Eli Lilly, Novo Nordisk, and Sanofi) have active voluntary programs capping out-of-pocket costs at $35 per month for many consumers, alongside low-cost generic biosimilars available at various retail pharmacies.
  • State-Level Laws: States like California implemented new rules capping co-pays at $35 per month for state-regulated private health plans and restricting deductibles on insulin.

What do diabetics do if they can't afford insulin?

If you cannot afford insulin, you should contact your doctor immediately to explore lower-cost alternatives, apply for manufacturer patient assistance programs, or go to a hospital emergency room if you are completely out of medicine.

Never ration or skip your insulin doses, as this can cause a life-threatening emergency called diabetic ketoacidosis (DKA).

Immediate Financial Relief and Programs

  • Manufacturer Caps: Major insulin makers cap out-of-pocket costs at $35 a month for many eligible patients. Check programs from Lilly Insulin Value Program, Novo Nordisk (Novocare), or Sanofi.
  • Access Tools: Use GetInsulin.org to find a personalized action plan based on your income, location, and prescription needs.
  • Immediate Emergency Supply: Some manufacturers offer a one-time, short-term emergency supply of insulin if you are at immediate risk of running out.

Alternative Low-Cost Options

  • Talk to Your Doctor: Ask your physician to prescribe older, generic, or lower-cost brands of insulin.
  • Over-the-Counter Insulins: Some pharmacies sell older formulations (like Regular or NPH insulin) without a prescription for a lower price. Use these only with caution and guidance from a doctor, as they are harder to manage and raise the risk of dangerous blood sugar drops.
  • Community Health Centers: Local clinics often provide sliding-scale fees or samples to patients in financial distress.

What will Medicare insulin coverage be in 2026?

In 2026, you can compare plans or view details on the Medicare Part D Plans for Insulin page, where your out-of-pocket cost for each covered insulin product is capped at no more than $35 for a one-month supply, with the yearly deductible waived.

Key Details for 2026 Insulin Coverage

  • Monthly Cost Cap: You pay a maximum of $35 per month (or less if 25% of the negotiated price or Maximum Fair Price is lower) for each covered insulin product under Medicare Part D and Part B.
  • Deductible Waived: The prescription drug deductible does not apply to covered insulin products.
  • Part B vs. Part D: Part B covers traditional pump-delivered insulin (where you may pay 20% of the approved amount after meeting the Part B deductible, unless a specific Part D rule applies), while Part D covers injectable, inhaled, and non-pump insulins with the $35 cap.
  • General Out-of-Pocket Limit: The total annual out-of-pocket cap for covered Part D prescription drugs reaches $2,100 in 2026, after which you pay $0 for covered drugs for the rest of the year.

What is the cheapest insulin without insurance?

Uninsured patients can buy traditional human insulin (like Novolin ReliOn) over-the-counter at major pharmacies like Walmart or CVS for around $25 per vial.

Cheap Insulin Options and Programs

  • Over-the-Counter Vials: Older human insulins (Novolin R and Novolin N) cost about $25 to $45 per vial without insurance. These require careful meal and timing management.
  • Manufacturer Savings Programs: Major companies cap modern analog insulins at $35 per month for uninsured people through dedicated savings initiatives:
    • Eli Lilly: The Lilly Insulin Value Program caps costs at $35 a month.
    • Sanofi: The Insulins Valyou Savings Program reduces costs to $35 a month.
    • Novo Nordisk: Offers savings options and patient assistance programs for qualifying low-income or uninsured individuals.
  • Discount Cards: Using services like GoodRx or SingleCare can lower brand-name and generic biosimilar prices (such as insulin glargine) significantly at local pharmacies.

How much is insulin at Walmart?

Walmart sells private-label ReliOn insulin options ranging from older human insulin formulations to rapid-acting analog insulin.

ReliOn Analog Insulin (Prescription Required)

  • ReliOn NovoLog Vials (10 mL): $72.88 per vial.
  • ReliOn NovoLog FlexPens (5-pack, 3 mL each): $85.88 per box.
  • ReliOn NovoLog Mix 70/30 Vials: $72.88 per vial.
  • ReliOn NovoLog Mix 70/30 FlexPens (5-pack): $85.88 per box.

Older Human Insulin Options

  • ReliOn Novolin (R, NPH, and 70/30): Historically priced around $25 per vial (prices can vary slightly by location and availability; check the Walmart Insulin Hub for local stock). These older human insulins do not act the same way as modern analog insulins and require specific doctor guidance.